BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 4156114)

  • 21. [Adrenergic beta receptor blockaders with intrinsic sympathomimetic activity in the treatment of arterial hypertension].
    Pyda M; Grajek S
    Kardiol Pol; 1988; 31(4):261-70. PubMed ID: 2906104
    [No Abstract]   [Full Text] [Related]  

  • 22. Renal and cardiac effects of antihypertensive treatment with ramipril versus metoprolol in autosomal dominant polycystic kidney disease.
    Steinman TI
    Nephrol Dial Transplant; 2008 Feb; 23(2):431-3. PubMed ID: 18065782
    [No Abstract]   [Full Text] [Related]  

  • 23. Different metabolic effects of selective and nonselective beta-blockers rather than mere heart rate reduction may be the mechanisms by which beta-blockade prevents cardiovascular events.
    Fragasso G; Cera M; Margonato A
    J Am Coll Cardiol; 2009 Jun; 53(22):2105; author reply 2106-7. PubMed ID: 19477370
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of arterial hypertension using beta-blockaders].
    Cottier P
    Ther Umsch; 1974 Nov; 31(11):772-8. PubMed ID: 4154519
    [No Abstract]   [Full Text] [Related]  

  • 25. [The rational selection of beta-blockers in the treatment of hypertension].
    Ter Arkh; 1999; 71(2):57-64. PubMed ID: 10222557
    [No Abstract]   [Full Text] [Related]  

  • 26. [Centra, peripheral, and volumetric hemodynamic changes in the treatment of essential hypertension with calcium antagonists and beta blockaders].
    Mattioli G; Ricci S; Teglio V
    Minerva Cardioangiol; 1980 May; 28(5):295-302. PubMed ID: 6111047
    [No Abstract]   [Full Text] [Related]  

  • 27. Beta-blockers as fourth-line therapy for hypertension: stay the course.
    Bangalore S; Messerli FH
    Int J Clin Pract; 2008 Nov; 62(11):1643-6. PubMed ID: 19143852
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of anapriline on myocardial contraction and systemic vascular resistance in patients with stage II hypertension].
    Tokarenko II
    Klin Med (Mosk); 1990 Dec; 68(12):15-7. PubMed ID: 1982154
    [No Abstract]   [Full Text] [Related]  

  • 29. Pindolol, (Visken, LB46). A new treatment for hypertension: report of a multicentric open study.
    Collins IS; King IW
    Curr Ther Res Clin Exp; 1972 Apr; 14(4):185-94. PubMed ID: 4402011
    [No Abstract]   [Full Text] [Related]  

  • 30. Position of beta blockers in antihypertensive therapy.
    J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S1-87. PubMed ID: 2439810
    [No Abstract]   [Full Text] [Related]  

  • 31. [Antihypertensive agents: adrenergic beta receptor blockaders].
    Ned Tijdschr Geneeskd; 1989 May; 133(21):1093-4. PubMed ID: 2567969
    [No Abstract]   [Full Text] [Related]  

  • 32. [The blood pressure profile, or how to establish the minimal effective dose of an antihypertensive agent].
    Abetel G
    Rev Med Suisse Romande; 1988 Jun; 108(6):529-33. PubMed ID: 2901140
    [No Abstract]   [Full Text] [Related]  

  • 33. [Proceedings: Antihypertensive effects of LB-46 (beta blockader)].
    Takeuchi N; Takekoshi J; Murakami E
    Jpn Circ J; 1975 Jul; 39(7):885. PubMed ID: 240046
    [No Abstract]   [Full Text] [Related]  

  • 34. The hypotensive action of LB 46.
    Doyle AE; Morgan TO; Louis WJ; Dawborn JK; Anavekar SN
    Indian Heart J; 1972 Jun; 24():Suppl 1:231-5. PubMed ID: 4147278
    [No Abstract]   [Full Text] [Related]  

  • 35. Therapy of hypertension: 1980.
    Hall WD
    J Med Assoc Ga; 1980 Sep; 69(9):745-8. PubMed ID: 6106659
    [No Abstract]   [Full Text] [Related]  

  • 36. [The new Russian preparation proxodolol in the treatment of arterial hypertension].
    Ol'binskaia LI; Morozova TE
    Eksp Klin Farmakol; 1994; 57(3):42-5. PubMed ID: 7914119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antihypertensive therapy in type 2 diabetes mellitus.
    Miser WF
    J Fam Pract; 1998 Dec; 47(6):413-4. PubMed ID: 9866657
    [No Abstract]   [Full Text] [Related]  

  • 38. [Pharmacokinetics of beta-blockers in arterial hypertension. Practical value].
    Safar M; Weiss Y; Chau NP; Kheder A; Levenson J; Milliez P
    Nouv Presse Med; 1978 Sep; 7(31):2759-60. PubMed ID: 30957
    [No Abstract]   [Full Text] [Related]  

  • 39. Antihypertensive effects of beta-blockers in hypertensive rats.
    Takeda K; Sakurai H; Imai S
    Jpn J Pharmacol; 1975 Feb; 25(1):82-3. PubMed ID: 239268
    [No Abstract]   [Full Text] [Related]  

  • 40. Experience with pindolol, a betareceptor blocker, in the treatment of hypertension.
    Atterhög JH; Dunér H; Pernow B
    Am J Med; 1976 May; 60(6):872-6. PubMed ID: 14501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.